Abstract
Cardiotoxic chemotherapy for early-stage breast cancer (EBC) increases the risk of heart failure (HF) but there are limited data on its prognosis relative to HF from other etiologies. Using administrative databases, we conducted a retrospective population-based matched cohort study of women newly
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
